Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-10 · accession 0001193125-26-045110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-10 | 2026-02-10 | AXSM | Coleman Mark | Dir | M - OptEx | $8.02 | +5,193 | 53.4K | +11% | +$41.6K |
| D | 2026-02-10 | 2026-02-10 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -5,193 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | M | A | 5,193 | $8.02 | 53,405 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-10 | M | D | 5,193 | $0.00 | 0 | D | $8.02 · 2017-05-27 to 2026-05-27 | 5,193 Common Stock |